Lung Cancer Trial, Recruiting NCT05094843 Sponsor: Tampere University Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT05094843
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults who are scheduled for planned (non-emergency) lung cancer surgery
  • People who are willing to take part in the study
  • People whose surgery is intended to fully remove or cure the cancer
  • People for whom a minimally invasive surgical approach has already been planned before the operation

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently taking part in another clinical trial
  • People who have a history of ongoing or recurring irregular heart rhythms, specifically atrial fibrillation or atrial flutter
  • People who have a cardiac pacemaker
  • People who have a history of problems with the heart's electrical signalling system, including bundle branch blocks
  • People who have previously had a procedure to treat abnormal heart rhythms using heat or cold (cardiac ablation)
  • People who have had previous surgery in the chest area, including open heart surgery
  • People for whom surgeons expect they will also need to remove part of the chest wall during the operation
  • People for whom open (non-minimally invasive) surgery is expected to be needed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jahangir Khan, MD, PhD

Phone: +3583311611

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tampere University Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2022
Est. completion
31 December 2028

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Postoperative electrocardiographic p-, R-, and T-wave amplitude changes; Postoperative QRS-duration; Postoperative PQ-delay; Postoperative QT-interval; The postoperative incidence of new bundle branch blocks; Postoperative ST-level changes; Postoperative P-wave, QRS-complex, and T-wave axle changes; Postoperative heart rate; Postoperative arrhythmias; Perioperative ST-level changes; Perioperative heart rate variability; Perioperative arrhythmias; Perioperative R- and T-wave amplitude changes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov